FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080085 [Registered on: 07/02/2025] Trial Registered Prospectively
Last Modified On:
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Other (Specify) [minimally invasive]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To compare outcomes of 3 percentage polidocanol sclerotherapy versus Modified Barrons rubber band ligation in the management of grade 2 internal hemorrhoidal disease  
Scientific Title of Study   Comparative analysis between outcomes of 3 percentage polidocanol sclerotherapy versus Modified Barrons rubber band ligation in the management of grade 2 internal hemorrhoidal disease : A non inferiority randomised control trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Swarnima Shubhadarshini 
Designation  junior resident 
Affiliation  all india institute of medical sciences patna  
Address  department of general surgery all india institute of medical sciences patna aurangabad road phulwari sharif patna bari khagaul bihar

Patna
BIHAR
801507
India 
Phone  7488836504  
Fax    
Email  shubhswarnima@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swarnima Shubhadarshini 
Designation  junior resident 
Affiliation  all india institute of medical sciences patna  
Address  department of general surgery all india institute of medical sciences patna aurangabad road phulwari sharif patna bari khagaul bihar


BIHAR
801507
India 
Phone  7488836504  
Fax    
Email  shubhswarnima@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shiv Shankar Paswan 
Designation  Additional Professor 
Affiliation  all india institute of medical sciences patna  
Address  department of general surgery opd aiims patna bihar 801507

Patna
BIHAR
801507
India 
Phone  6370225503  
Fax    
Email  shiv@aiimspatna.org  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  AIIMS Patna  
Address  All India Institute of Medical Sciences Patna Aurangabad road Phulwari Sharif Patna Bari Khagaul Bihar 801507  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
nil   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Swarnima Shubhadarshini  All India Institute of Medical Sciences Patna   Department of General Surgery Third floor Aurangabad road Phulwari Sharif Patna Bari Khagaul Bihar
Patna
BIHAR 
7488836504

shubhswarnima@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee AIIMS Patna  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K641||Second degree hemorrhoids,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  3 percentage polidocanol  In group A the participants will be treated with 4 ml 3 percentage polidocanol foam via generously lubricated Kelly proctoscope Modified Tessari technique will be used for preparation of polidocanol foam and will be applied immediately to prevent disintegration of microbubbles With patient in Jackknife position foam will be injected using 20 ml disposable syringe with a 20 G spinal needle adapted as a syringe connected to the 20 ml foam syringe Maximum dose per treatment session used is 20 ml: 4 ml sclerosant containing 120 mg polidocanol mixed with 16 ml air More than one haemorrhoidal nodule can be treated in single session 
Comparator Agent  Barrons rubber band ligation  In group B participants will be placed in jackknife position and visualisation will be done by using a generously lubricated Kelly proctoscope Modified Barrons rubber band ligation technique will be used They will be treated with 2 rubber bands placed around redundant rectal mucosa which was grasped proximally using a clamp A reusable metal ligation device connected to suction channel McGown suction was used for this purpose Clamp will thereafter released More than one haemorrhoidal pedicle can be ligated during a single session 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Age 18 years or older with grade 2 hemorrhoidal disease giving consent for participation
Refractory to conservative management given for at least 1 month 
 
ExclusionCriteria 
Details  Grade 1 3 and 4 hemorrhoidal disease
Associated complications like strangulation or thrombosis
Patients with external hemorrhoids
Associated perianal fissure or fistula
Patients who have undergone treatment for hemorrhoidal disease within last 12 months regardless of the type of treatment
Patients with Inflammatory Bowel Disease
Patients with coagulopathies arising from any cause or on anti-coagulation therapy
Immunocompromised individuals
Pregnant females
 
 
Method of Generating Random Sequence   Stratified block randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the patient related outcomes blood loss pain prolapse itching soiling of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease using Patient Reported Outcome Measures Haemorrhoidal Impact and Satisfaction Score PROM HISS questionnaire   day 0
1 week
6 weeks
3 months 
 
Secondary Outcome  
Outcome  TimePoints 
To assess the complication rate of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease  6 weeks
3 months 
To assess the recurrence rate of 3 percentage polidocanol Sclerotherapy as compared to Modified Barrons Rubber Band Ligation in treatment of grade 2 internal haemorrhoidal disease where recurrence means subjective return of symptoms as told by patient  3 months 
 
Target Sample Size   Total Sample Size="332"
Sample Size from India="332" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   09/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study will be conducted in the Department of General Surgery AIIMS Patna and will include patients with Grade 2 Internal Hemorrhoidal Disease who have undergone at least one month of conservative management including dietary and lifestyle modifications along with medical management using Micronised Purified Flavonoid Fraction and have not experienced symptom relief Eligible patients will be randomized into two parallel groups Group A receiving 3 percentage Polidocanol Sclerotherapy and Group B undergoing Modified Barrons Rubber Band Ligation with an allocation ratio of 1 to 1 Patients who refuse randomization will be allowed to choose their preferred treatment modality The Sclerotherapy group will receive 4 ml of 3 percentage Polidocanol foam prepared using the Modified Tessari technique and injected via a Kelly proctoscope in the Jackknife position with a maximum dose of 20 ml per session treating multiple nodules if necessary The RBL group will undergo ligation in the Jackknife position using a Kelly proctoscope and a reusable metal ligation device with suction applying two rubber bands per hemorrhoidal pedicle if required Patient related outcomes will be assessed using the Patient Reported Outcome Measure Hemorrhoidal Impact and Satisfaction Score PROM HISS questionnaire which evaluates hemorrhoidal symptoms impact on daily activities and satisfaction with treatment Follow up visits will be conducted at 1 week 6 weeks and 3 months with potential retreatment at 6 weeks if necessary Data will be analyzed on both an intention to treat and per protocol basis with the total study duration expected to be between 1 to 1 year 6 months

 
Close